Direct2Attorney is a legal marketing & referral service - not a law firm and not a substitute for legal advice.

Your Experience Matters!
Join the Fight for Justice Today

Why Share Your Story?

advanced divider

Fill Out the Form Below
What We Need

advanced divider

Why Request a Free Case Review Through Direct2Attorney?

advanced divider

Get Started Now!

Complete the form and take the first step towards justice and compensation. Your story can make a difference!

Free Case Review

Takes about 2 minutes No cost No obligation

Services Single Form With Logic

What Is Depo-Provera?

Depo-Provera is a widely used injectable birth control developed by Upjohn (now Pfizer). Approved by the FDA in 1992, it delivers medroxyprogesterone acetate every three months to prevent pregnancy by stopping ovulation and altering cervical mucus. Since its introduction, millions of women have chosen it for its convenience. However, early concerns about side effects like bone density loss and cancer risks sparked debates, with the FDA initially rejecting approval in the 1970s due to safety concerns. Despite its popularity, recent evidence suggests serious health risks were not adequately disclosed.

Get Compensated for Your Injustice—Start Your Claim Today!

At Direct2Attorney, we believe in your right to justice.

01process 2 icon 1

Take the First Step

Fill out the form on our page to share your experience

02process 2 icon 2

Expert Case Review

Our legal specialists will review your case thoroughly to identify your options.

03process 2 icon 3

Guided Legal Support

We will assess your eligibility and assist you in filing your case, ensuring you feel supported throughout the process.

Depo-Provera and Brain Tumor Risks

Research has examined a possible association between long-term Depo-Provera use and certain medical conditions, including intracranial meningiomas. Individuals who believe they were affected may wish to request a free case review to understand their legal options.

Take Control of Your Depo-Provera Claim

If you’ve experienced health issues due to Depo-Provera, we are here to help you secure the compensation you deserve. Contact Us

Latest Developments in Depo-Provera Lawsuits

As of April 2025, the Depo-Provera litigation is heating up. An MDL in Florida’s Northern District, led by Judge M. Casey Rodgers, consolidates 27 lawsuits, with thousands more expected. Five bellwether cases are set for trials, with key deadlines in July and August 2025. Recent filings in Nevada, Missouri, and California highlight devastating cases of inoperable tumors. A Pennsylvania class action seeks medical monitoring for at-risk women. Law firms, including direct2attorney, are urging affected women to act fast, as statutes of limitations vary by state.

Frequently Asked Questions

What is the Depo-Provera lawsuit about?

Lawsuits claim Pfizer failed to warn about the risk of brain tumors, like meningiomas, linked to Depo-Provera, causing severe health issues.

Who can file a Depo-Provera lawsuit?

Women diagnosed with brain tumors (e.g., meningiomas) after using Depo-Provera, and their families, may qualify with proof of use and diagnosis.

What are the health risks of Depo-Provera?

Risks include brain tumors, bone density loss, blood clots, and possible increased risks of breast or cervical cancer with long-term use.

What compensation is available in a Depo-Provera lawsuit?

You may seek damages for medical costs, pain and suffering, lost wages, and other losses tied to brain tumor diagnosis and treatment

How long do I have to file a lawsuit?

Deadlines vary by state, typically one to several years from diagnosis or learning of the tumor link. An attorney can clarify your timeline.

What’s the status of Depo-Provera lawsuits in 2025?

Lawsuits are consolidated in a Florida MDL, with trials planned and new cases accepted. The litigation is expected to expand rapidly.

How do I find a Depo-Provera lawsuit attorney?

Contact direct2attorney’s experienced mass tort lawyers for a free consultation to evaluate your claim and guide you through the process.